As COO at MD Education, I am leading efforts to redefine medical education by collaborating with the world's most renowned medical doctors.

Vienna, Austria
Joined March 2018
Fantastic presentation by Karim Fizazi! PEACE-1 at 7.7 years: adding abiraterone to ADT + docetaxel improved median OS to 6.2 vs 4.4 years (HR 0.68) in de novo mCSPC. Durable benefit from upfront intensification! @myESMO #ESMO26 @oncoalert
32
2
76
3,934
Simon Mayr retweeted
FOURLIGHT-1 beautifully presented by @antgiorda Fulvestrant + atirmociclib (cdk4i) vs Fulvestrant or exemestane + everolimus All had prior CDK 4/6i PFS 9.9 vs 6.6 HR 0.60 p=0.0007 @OncoAlert @DFCI_BreastOnc
29
1
53
3,773
Encouraging OS results in neuroendocrine prostate cancer at #ESMO26! #KEYNOTE-365 evaluated pembrolizumab + carboplatin/etoposide vs chemotherapy alone. • mOS: 10.2 vs 7.1 months (HR 0.33) • rPFS: 5.1 vs 4.0 months (HR 0.66) • PD-L1 CPS ≥1: mOS 11.0 vs 4.8 months (HR 0.16) No new safety signals observed. @myESMO @oncoalert
2
51
3
111
6,603
⏳ 4 weeks to go! 2nd Annual Women in Hematology US Focus Meeting 📍 Hilton Austin, TX 📅 Nov 6–7, 2026 26 expert faculty, 8 sessions, led by wonderful co-chairs @sanamloghavi @SoniSmithMD @DrKrinaPatel #WomenInHematology #Hematology #projectmanagement
2
8
440
As amazing as the @_MDEducation EU focus meeting was, Lisbon and the company was also special. @matteolambe @hoperugo @JavierCortesMD #bcsm
5
34
1,634
That's a wrap on our inaugural Breast Cancer EU Focus Meeting in Lisbon. Two days at the SANA Malhoa with a great faculty from across Europe and the US, covering everything from HER2+ and TNBC to HR+ early and metastatic disease, ADC sequencing and risk-reducing strategies for BRCA1/2 carriers. The panel discussions were exactly what we hoped for: open, practical, and very much driven by the fellows in the room. A big thank you to our co-chairs @VKaklamani and @JavierCortesMD for building such a strong program, and to all faculty for their time and contributions. Also to @TinnaCriss1, who managed this meeting from first draft to final session - a great job on a first edition. Looking forward to the 2027 edition. #BreastCancer #MedicalEducation #Oncology #Lisbon
1
1
12
1,221
Second day of @_MDEducation Breast Cancer EU Focus Meeting with answers to the predictive value of TILs in TNBC and the future of ADCs @lab_kok @hoperugo
1
8
30
1,025
What an amazing first day of @_MDEducation Breast Cancer EU meeting in beautiful Lisbon @JavierCortesMD @hoperugo @BianchiniGP @lab_kok @matteolambe @BarbaraPistill2 #bcsm
1
8
27
1,155
Such a great meeting with very timely topics @jhaveri_komal
Uploading the highlight video from the Breast Cancer Meeting two weeks ago — still feeling the thrill! The amazing feedback from the faculty made it even more special. Already excited for next year! ✨#breastcancer #livemeetings
4
2
17
2,028
Lung Cancer US Focus Meeting 2026 is officially complete — and what a fantastic event it was in Nashville! A huge thank you to our chairs @StephenVLiu and @CharuAggarwalMD , faculty, fellows, supporters, attendees, and the on site team! Already looking forward to next year!
2
4
11
1,361
Just 2 weeks to go until the Lung Cancer US Focus Meeting 2026 - and I’m really looking forward to it! We’re bringing together a brilliant faculty and a highly engaged audience for two days of meaningful, discussion-driven exchange #LungCancer #projectmanagement #eventmanagement
1
3
43
Here’s the #BreastCancer Research Digest-a summary of last week’s publications from select high-impact journals (March 27th - April 3rd, 2026). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch #BreastCancer
1
14
1
23
1,984
Simon Mayr retweeted
After three incredible years, the Women in IBD EU Focus Meeting returns for its 4th edition in Rome! 🇮🇹 Co-chaired by @MLongMD and Joana Torres, MD and packed with an international faculty of outstanding women in IBD. November 13–14, 2026 | Rome, Italy 🔗 md-education.com/women-in-ib…
2
2
298
Simon Mayr retweeted
At our Inaugural Breast Cancer US Focus Meeting, Ian Krop, MD highlighted the rapidly evolving HER2-positive breast cancer treatment landscape. He returns for our 2nd Annual Meeting on April 24 - 25, 2026. md-education.com/breast-canc…
1
2
347
Simon Mayr retweeted
Another outstanding session at the CLL & Lymphoma EU Focus Meeting 2026 in Lisbon. Session VI covered the full patient journey in CLL treatment sequencing. From front-line targeted therapy to bispecific antibodies, CARs, and managing double exposed and double refractory disease. #MDEducation
2
3
318
Simon Mayr retweeted
Two experts. Two approaches. One great debate. 🎯 @LiaPalomba and @YucaiWangMD faced off on CAR-T vs Bispecifics in Mantle Cell Lymphoma. Sign up for the recordings: links.md-education.com/Cell_… #MDEducation @Daver_Leukemia @JoshuaRichterMD
3
11
646
Simon Mayr retweeted
Exciting News! Our Inaugural CLL & Lymphoma EU Focus Meeting 2026 is CME accredited 👏🏻 Earn 10.0 ECMEC®s while learning from Europe's leading experts in CLL and lymphoid malignancies. Chaired by Prof. Stephan Stilgenbauer & Prof. Franck Morschhauser, two of the most respected names in the field. 🔗 Register now: md-education.com/cll-lymphom… #MDEducation #Hematology @HemostasisToday @Jessica_Okosun @tobyeyre82 @gloria_iacoboni @MJerkeman
3
6
515
Simon Mayr retweeted
We wrapped up an extraordinary three days in Puerto Rico with a deep dive into CML and CLL. Yesterday, we heard from global experts like Daniel DeAngelo, MD, and @mjmauroMD on the nuances of CML frontline and relapse management, followed by a comprehensive CLL update from William Wierda, MD. Sign up for the recordings: links.md-education.com/pan_h… #MDEducation @Daver_Leukemia @Ramikomrokji
2
3
605
Simon Mayr retweeted
Empowering Women in Medicine: Mentorship and Growth was one of the most inspiring sessions at the Women In Hematology US Focus Meeting 2025. Featuring @LNastoupilMD, Neha Mehta-Shah, MD, MSCI, @DrKrinaPatel, and Ross Levine, MD, this session highlighted women leading transformative advances in myeloma research, lab-based innovation, and collaborative initiatives with disease organizations such as LRF. Truly inspiring from start to finish. 🎥 Recordings are available to watch here: academy.md-education.com/cou… #MDEducation @sanamloghavi
2
3
271
Simon Mayr retweeted
Dr. Stephan Stilgenbauer highlights why the CLL & Lymphoma EU Focus Meeting 2026 is a unique opportunity for both established experts and early-career clinicians. Its intimate format enables direct, face-to-face exchange with a wide range of key opinion leaders from across the globe. 🌏 This year’s program showcases key advances in disease biology and patient care, spanning trial design, MRD assessment, treatment resistance, and treatment sequencing. Read the full agenda and join us: md-education.com/cll-lymphom… 🗓 March 13–14, 2026 | 📍 Lisbon, Portugal
2
3
188